Rilparencel leads to kidney function stabilisation in chronic kidney disease and type 2 diabetes Presented ByDr Joseph Stavas, ProKidney LLC, Winston-Salem, NC, USA TrialPhase 2, REACT ConferenceERA 2024 TypeNews article 20 June 2024 18:13
Quiescent disease, characteristics and biomarker correlations TrialREACT, CALM ConferenceECCO 2018 TypePeer-reviewed article 28 May 2018 23:54